The role of dexamethasone on decreasing urinary cytokines in children with acute pyelonephritis
- PMID: 18551321
- DOI: 10.1007/s00467-008-0864-4
The role of dexamethasone on decreasing urinary cytokines in children with acute pyelonephritis
Abstract
Cytokines play a major role in renal scar formation following febrile urinary tract infection (UTI). We investigated the role of dexamethasone combined with antibiotics in diminishing urinary interleukin-6 (UIL-6) and UIL-8 concentrations during the acute phase of pyelonephritis compared with standard antibiotic therapy. UIL-6 and UIL-8 concentrations were determined by enzyme immunoassay in 34 children with pyelonephritis who were treated with ceftriaxone plus dexamethasone (case group) and in 20 patients with the same diagnosis treated with ceftriaxone alone (control group). Urine samples were obtained at the time of presentation prior to drug administration and at follow-up 72 h after initiation of medication. Creatinine concentrations were also determined, and cytokine/creatinine ratios were calculated to standardize samples. Differences between cytokine/creatinine ratios in initial and follow-up urine samples were significant in the case group (P < 0.001) but not for controls. In addition, combined antibiotic and dexamethasone significantly decreased UIL-6 and UIL-8 concentrations compared with antibiotic alone (P < 0.05). We conclude that dexamethasone combined with antibiotics significantly decreases UIL-6 and UIL-8 levels in patients with acute pyelonephritis. This suggests that the clinical use of corticosteroids may prevent scar formation following febrile UTI.
Similar articles
-
Assessment the Effect of Dexamethasone on Urinary Cytokines and Renal Scar in Children with Acute Pyelonephritis.Iran J Kidney Dis. 2019 Jul;13(4):244-250. Iran J Kidney Dis. 2019. PMID: 31422390 Clinical Trial.
-
Urinary concentration of cytokines in children with acute pyelonephritis.Eur J Pediatr. 2013 Jun;172(6):769-74. doi: 10.1007/s00431-012-1914-2. Epub 2013 Feb 7. Eur J Pediatr. 2013. PMID: 23389820
-
Urinary interleukin-6 and interleukin-8 in children with urinary tract infection.Pediatr Nephrol. 2000 Dec;15(3-4):236-40. doi: 10.1007/s004670000456. Pediatr Nephrol. 2000. PMID: 11149117 Clinical Trial.
-
Antibiotic treatment for urinary tract infections in pediatric patients.Minerva Pediatr. 2003 Oct;55(5):395-406. Minerva Pediatr. 2003. PMID: 14608263 Review.
-
Adjuvant corticosteroids for prevention of kidney scarring in children with acute pyelonephritis: a systematic review and meta-analysis.Arch Dis Child. 2021 Nov;106(11):1081-1086. doi: 10.1136/archdischild-2020-320591. Epub 2021 Feb 25. Arch Dis Child. 2021. PMID: 33632785
Cited by
-
Use of antioxidants in urinary tract infection.J Res Pharm Pract. 2016 Apr-Jun;5(2):79-85. doi: 10.4103/2279-042X.179567. J Res Pharm Pract. 2016. PMID: 27162800 Free PMC article. Review.
-
The effect of vitamin E or vitamin A on the prevention of renal scarring in children with acute pyelonephritis.Pediatr Nephrol. 2013 Feb;28(2):277-83. doi: 10.1007/s00467-012-2308-4. Epub 2012 Oct 7. Pediatr Nephrol. 2013. PMID: 23052650 Clinical Trial.
-
The effect of vitamin A on renal damage following acute pyelonephritis in children.Eur J Pediatr. 2011 Mar;170(3):347-50. doi: 10.1007/s00431-010-1297-1. Epub 2010 Sep 18. Eur J Pediatr. 2011. PMID: 20853007 Clinical Trial.
-
Urine IL-8 concentrations in infectious and non-infectious urinary tract conditions.Pediatr Nephrol. 2011 Nov;26(11):2003-7. doi: 10.1007/s00467-011-1909-7. Epub 2011 May 21. Pediatr Nephrol. 2011. PMID: 21603907
-
The efficacy and safety of corticosteroids in pediatric kidney scar prevention after urinary tract infection: a systematic review and meta-analysis of randomized clinical trials.Pediatr Nephrol. 2023 Dec;38(12):3937-3945. doi: 10.1007/s00467-023-05922-0. Epub 2023 Mar 21. Pediatr Nephrol. 2023. PMID: 36943468 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources